Influence of sex on the persistence of different classes of targeted therapies for psoriatic arthritis: a cohort study of 14 778 patients from the French health insurance database (SNDS).
Laura Pina VegasLaetitia PensoEmilie SbidianPascal ClaudepierrePublished in: RMD open (2023)
The treatment persistence was lower for women than men for TNFi and IL17i but not for IL12/23i, IL23i or JAKi.
Keyphrases
- health insurance
- end stage renal disease
- ejection fraction
- chronic kidney disease
- affordable care act
- prognostic factors
- polycystic ovary syndrome
- type diabetes
- peritoneal dialysis
- healthcare
- middle aged
- patient reported outcomes
- combination therapy
- skeletal muscle
- adipose tissue
- pregnancy outcomes
- patient reported
- cervical cancer screening
- replacement therapy